Is Evotec SE Stock a Good Investment?
Evotec SE Investment Advice | EVO |
- Examine Evotec SE's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Evotec SE's leadership team and their track record. Good management can help Evotec SE navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Evotec SE's business and its evolving consumer preferences.
- Compare Evotec SE's performance and market position to its competitors. Analyze how Evotec SE is positioned in terms of product offerings, innovation, and market share.
- Check if Evotec SE pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Evotec SE's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Evotec SE ADR stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Evotec SE ADR is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Good | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Evotec SE Stock
Researching Evotec SE's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 1.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evotec SE ADR has Price/Earnings (P/E) ratio of 444.0. The entity recorded a loss per share of 0.52. The firm last dividend was issued on the 12th of December 2018. Evotec SE had 4:1 split on the 20th of October 2021.
To determine if Evotec SE is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Evotec SE's research are outlined below:
| Evotec SE ADR is way too risky over 90 days horizon | |
| Evotec SE ADR appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 781.43 M. Reported Net Loss for the year was (83.91 M) with profit before taxes, overhead, and interest of 151.54 M. | |
| Latest headline from finance.yahoo.com: Catalyst Metals And 2 Other ASX Penny Stocks To Watch |
Evotec SE Quarterly Good Will |
|
Evotec SE uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Evotec SE ADR. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evotec SE's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Evotec SE's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Evotec SE's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-26 | 2023-12-31 | -0.03 | -0.05 | -0.02 | 66 | ||
2024-11-06 | 2024-09-30 | -0.08 | -0.12 | -0.04 | 50 | ||
2024-05-22 | 2024-03-31 | -0.1 | -0.06 | 0.04 | 40 | ||
2023-11-08 | 2023-09-30 | -0.05 | -0.12 | -0.07 | 140 | ||
2022-08-11 | 2022-06-30 | 0.03 | -0.08 | -0.11 | 366 | ||
2021-12-31 | 2021-12-31 | 0.06 | -0.11 | -0.17 | 283 | ||
2023-05-12 | 2023-03-31 | 0.1 | -0.08 | -0.18 | 180 | ||
2024-08-14 | 2024-06-30 | -0.06 | -0.2882 | -0.2282 | 380 |
Know Evotec SE's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Evotec SE is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evotec SE ADR backward and forwards among themselves. Evotec SE's institutional investor refers to the entity that pools money to purchase Evotec SE's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-06-30 | 11.4 K | Adar1 Capital Management Llc | 2024-06-30 | 9.4 K | Quadrant Capital Group Llc | 2024-09-30 | 6.2 K | Bank Of America Corp | 2024-06-30 | 6 K | Signaturefd, Llc | 2024-09-30 | 5.2 K | Briaud Financial Planning Inc | 2024-09-30 | 2.2 K | Lindbrook Capital, Llc | 2024-06-30 | 2.1 K | U.s. Bancorp | 2024-06-30 | 1.7 K | Parallel Advisors, Llc | 2024-06-30 | 1.5 K | Novo A/s | 2024-06-30 | 14.8 M | Mubadala Investment Company Pjsc | 2024-06-30 | 4.6 M |
Evotec SE's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.7 B.Market Cap |
|
Evotec SE's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Capital Employed | (0.03) | (0.03) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.07) | (0.08) |
Determining Evotec SE's profitability involves analyzing its financial statements and using various financial metrics to determine if Evotec SE is a good buy. For example, gross profit margin measures Evotec SE's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Evotec SE's profitability and make more informed investment decisions.
Evaluate Evotec SE's management efficiency
Evotec SE ADR has Return on Asset of (0.0177) % which means that on every $100 spent on assets, it lost $0.0177. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1625) %, meaning that it generated no profit with money invested by stockholders. Evotec SE's management efficiency ratios could be used to measure how well Evotec SE manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -0.04. In addition to that, Return On Capital Employed is likely to drop to -0.03. At this time, Evotec SE's Intangibles To Total Assets are very stable compared to the past year. As of the 22nd of November 2024, Debt To Assets is likely to grow to 0.20, while Other Assets are likely to drop 1.09.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.33 | 6.01 | |
| Tangible Book Value Per Share | 4.68 | 4.45 | |
| Enterprise Value Over EBITDA | 82.60 | 86.73 | |
| Price Book Value Ratio | 1.68 | 1.67 | |
| Enterprise Value Multiple | 82.60 | 86.73 | |
| Price Fair Value | 1.68 | 1.67 | |
| Enterprise Value | 2 B | 2.1 B |
The leadership approach at Evotec SE's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.984 |
Basic technical analysis of Evotec Stock
As of the 22nd of November, Evotec SE shows the Coefficient Of Variation of 597.7, mean deviation of 4.02, and Downside Deviation of 4.99. Evotec SE ADR technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Evotec SE's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evotec SE insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evotec SE's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evotec SE insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zientek Michael over three months ago Acquisition by Zientek Michael of 200000 shares of Evotec SE at 2.5 subject to Rule 16b-3 | ||
Zientek Michael over three months ago Disposition of tradable shares by Zientek Michael of Evotec SE subject to Rule 16b-3 | ||
Anderson Mark Monroe over six months ago Acquisition by Anderson Mark Monroe of 100000 shares of Evotec SE at 2.5 subject to Rule 16b-3 |
Evotec SE's Outstanding Corporate Bonds
Evotec SE issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Evotec SE ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Evotec bonds can be classified according to their maturity, which is the date when Evotec SE ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Evotec SE's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Evotec SE's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1347 | |||
| Market Risk Adjusted Performance | (2.58) | |||
| Mean Deviation | 4.02 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.99 | |||
| Coefficient Of Variation | 597.7 | |||
| Standard Deviation | 5.45 | |||
| Variance | 29.69 | |||
| Information Ratio | 0.1498 | |||
| Jensen Alpha | 0.9315 | |||
| Total Risk Alpha | 0.2839 | |||
| Sortino Ratio | 0.1636 | |||
| Treynor Ratio | (2.59) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 9.82 | |||
| Downside Variance | 24.89 | |||
| Semi Variance | 19.45 | |||
| Expected Short fall | (4.67) | |||
| Skewness | 0.2808 | |||
| Kurtosis | 1.66 |
| Risk Adjusted Performance | 0.1347 | |||
| Market Risk Adjusted Performance | (2.58) | |||
| Mean Deviation | 4.02 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.99 | |||
| Coefficient Of Variation | 597.7 | |||
| Standard Deviation | 5.45 | |||
| Variance | 29.69 | |||
| Information Ratio | 0.1498 | |||
| Jensen Alpha | 0.9315 | |||
| Total Risk Alpha | 0.2839 | |||
| Sortino Ratio | 0.1636 | |||
| Treynor Ratio | (2.59) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 9.82 | |||
| Downside Variance | 24.89 | |||
| Semi Variance | 19.45 | |||
| Expected Short fall | (4.67) | |||
| Skewness | 0.2808 | |||
| Kurtosis | 1.66 |
Consider Evotec SE's intraday indicators
Evotec SE intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Evotec SE stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Evotec SE Corporate Filings
6K | 15th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
F3 | 8th of November 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
| 14th of August 2024 Other Reports | ViewVerify | |
| 30th of April 2024 Other Reports | ViewVerify |
Evotec Stock media impact
Far too much social signal, news, headlines, and media speculation about Evotec SE that are available to investors today. That information is available publicly through Evotec media outlets and privately through word of mouth or via Evotec internal channels. However, regardless of the origin, that massive amount of Evotec data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evotec SE news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evotec SE relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evotec SE's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evotec SE alpha.
Evotec SE Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Evotec SE can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Evotec SE Corporate Management
| Matthias Evers | Chief Board | Profile | |
| Monika Conradt | Global Resources | Profile | |
| MBA MPA | Member Board | Profile | |
| Christian Dargel | EVP Compliance | Profile | |
| Anja Bosler | Principal Accounting | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 2.1925 | Quarterly Revenue Growth (0.06) | Return On Assets (0.02) | Return On Equity (0.16) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Evotec SE's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.